Literature DB >> 18789654

Reductions in frontal, temporal and parietal volume associated with the onset of psychosis.

Stefan J Borgwardt1, Philip K McGuire, Jacqueline Aston, Ute Gschwandtner, Marlon O Pflüger, Rolf-Dieter Stieglitz, Ernst-Wilhelm Radue, Anita Riecher-Rössler.   

Abstract

BACKGROUND: Volumetric MRI abnormalities similar to those evident in schizophrenia are also evident in people at very high risk of psychosis. Which volumetric abnormalities are related to psychotic illness, as opposed to vulnerability to psychosis is unclear. The aim of the study was to compare regional gray matter volume in people before and after the onset of psychosis using a within-subject prospective design.
METHODS: MRI data were acquired from individuals when they presented with an at-risk mental state (ARMS, n=20). Over the following 3 years, 10 subjects developed psychosis and 10 did not. Subjects were re-scanned after the onset of psychosis or at the end of follow-up if they did not become psychotic. Images were processed and analyzed using voxel-based morphometry (SPM5).
RESULTS: In subjects who developed psychosis there were longitudinal volume reductions in the orbitofrontal, superior frontal, inferior temporal, medial and superior parietal cortex, and in the cerebellum. There were no longitudinal changes in subjects who did not develop psychosis.
CONCLUSIONS: The onset of psychosis was associated with a reduction in gray matter volume in frontal, temporal and parietal cortex. These abnormalities may be particularly associated with psychotic illness, as opposed to a vulnerability to psychosis.

Entities:  

Mesh:

Year:  2008        PMID: 18789654     DOI: 10.1016/j.schres.2008.08.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  84 in total

1.  Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.

Authors:  Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni
Journal:  Schizophr Bull       Date:  2010-06-10       Impact factor: 9.306

2.  An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?

Authors:  Ramadhan Oruch; Anders Lund; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2010-01-27

Review 3.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

4.  Progressive structural brain changes during development of psychosis.

Authors:  Tim B Ziermans; Patricia F Schothorst; Hugo G Schnack; P Cédric M P Koolschijn; René S Kahn; Herman van Engeland; Sarah Durston
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

5.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

Review 6.  [Frontal brain volume reduction due to antipsychotic drugs?].

Authors:  V Aderhold; S Weinmann; C Hägele; A Heinz
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

Review 7.  Brain imaging during the transition from psychosis prodrome to schizophrenia.

Authors:  Yoonho Chung; Tyrone D Cannon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

8.  Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis.

Authors:  Nicolas A Crossley; Andrea Mechelli; Paolo Fusar-Poli; Matthew R Broome; Pall Matthiasson; Louise C Johns; Elvira Bramon; Lucia Valmaggia; Steven C R Williams; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

Review 9.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

Review 10.  Brain Biomarkers of Vulnerability and Progression to Psychosis.

Authors:  Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.